首頁 > 市場調查報告書 > 製藥

2030 年歐洲痤瘡藥物市場預測 - 區域分析 - 按治療類別、配方、類型、痤瘡類型和配銷通路

市場調查報告書

商品編碼

1567804

2030 年歐洲痤瘡藥物市場預測 - 區域分析 - 按治療類別、配方、類型、痤瘡類型和配銷通路

Europe Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

出版日期: 2024年08月07日 | 出版商:

The Insight Partners | 英文 127 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲痤瘡藥物市場價值為19.6308億美元，預計到2030年將達到31.1269億美元；預計 2023 年至 2030 年複合年成長率為 6.0%。

基於尖端技術和數據驅動策略的個人化治療方案推動歐洲痤瘡藥物市場

在歐洲痤瘡藥物市場中採用先進技術和數據驅動的方法開闢了新的研發途徑。透過收集和分析患者資料，研究人員可以獲得有關痤瘡根本原因的寶貴見解，確定治療反應的模式和趨勢，並發現治療干預的新潛在目標。這可以推動新型藥物、創新治療策略以及針對痤瘡患者多樣化需求的個人化護膚產品的開發。透過利用人工智慧 (AI)、機器學習演算法、基因檢測和其他尖端工具，醫療保健提供者現在可以分析大量資料，以更好地了解患者獨特的皮膚狀況、遺傳傾向、生活方式因素和治療反應。這種個人化方法可以製定專門針對每個患者的個人需求而設計的客製化治療計劃。

2021 年 3 月，Thorne HealthTech 旗下健康情報公司 Onegevity 與全球頂級美容和個人護理產品製造商之一聯合利華合作，推出更個人化的痤瘡介入和治療方法。此次科學合作旨在研究多組學或不同生物學學科整合的潛力，以實現更個人化的痤瘡治療方法。此次合作旨在創建新的診斷模型，利用 Onegevity 的人工智慧和機器學習功能來解鎖客製化的痤瘡治療計劃，從而評估影響個人健康的數十億個生物特徵。個人化治療計劃透過考慮患者的特定特徵和可能影響其對痤瘡藥物反應的因素來幫助最佳化治療效果。根據此類患者特定資料，醫療保健提供者可以開出更可能對該特定個體有效的治療方法。這提高了成功治療痤瘡的機會，並減少了副作用和不良反應的可能性，從而改善了患者的治療效果並提高了滿意度。因此，整合先進技術和數據驅動的方法來設計個人化治療計劃，為歐洲痤瘡藥物市場的創新、成長和改善患者治療結果創造了重大機會。

歐洲痤瘡藥物市場概況

歐洲在全球痤瘡藥物市場中排名第二。預計在預測期內將出現顯著的複合年成長率。該地區痤瘡藥物市場的成長歸因於痤瘡盛行率的增加和主要參與者的不斷增加。以研究為基礎的製藥業可以在支持歐洲痤瘡藥物市場成長並確保其未來在全球經濟中的競爭力方面發揮關鍵作用。總部位於柏林的 Formel Skin 是皮膚科遠距醫療領域的先驅，宣佈於 2022 年 1 月完成了 32.35 (30) 萬美元的系列融資。 Heartcore Capital 與Vorwerk Ventures。利用這筆資金，該公司計劃對其遠端護膚平台進行長期開發和擴展。

歐洲痤瘡藥物市場收入及 2030 年預測（百萬美元）

歐洲痤瘡藥物市場細分

歐洲痤瘡藥物市場根據治療類別、配方、類型、痤瘡類型、配銷通路和國家進行細分。

根據治療類別，歐洲痤瘡藥物市場分為類維生素A、過氧化苯甲醯、抗生素、水楊酸等。 2022 年，類視黃醇細分市場佔據最大佔有率。

從劑型來看，歐洲痤瘡藥物市場分為外用藥物和口服藥物。 2022 年，外用藥物領域佔據更大的佔有率。

按類型分類，歐洲痤瘡藥物市場分為處方藥和非處方藥。 2022 年，處方藥領域佔據更大的最大佔有率。

根據痤瘡類型，歐洲痤瘡藥物市場分為非發炎性痤瘡和發炎性痤瘡。 2022 年，發炎性痤瘡部分佔據了更大的佔有率。

在配銷通路方面，歐洲痤瘡藥物市場分為藥局和藥局、零售店和電子商務。 2022 年，藥局和藥局細分市場佔據最大佔有率。

根據國家/地區，歐洲痤瘡藥物市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲痤瘡藥物市場佔據主導地位。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Almirall SA、強生公司、Bausch Health Companies Inc、Galderma SA、輝瑞公司、GSK Plc、Viatris Inc 和 Pierre Fabre SA 是歐洲痤瘡藥物領域的一些領先公司市場。

歐洲痤瘡藥物市場 - 主要市場動態
主要市場促進因素
- 嚴重痤瘡的盛行率不斷增加
- 新藥上市
主要市場限制
- 與痤瘡藥物相關的副作用
主要市場機會
- 基於尖端技術和數據驅動策略的個人化治療方案
未來趨勢
- 對有機和自然療法的需求激增
促進因素和限制的影響：

第 6 章：痤瘡藥物市場 - 歐洲市場分析

第 7 章：歐洲痤瘡藥物市場分析 - 按治療類別

類維生素A
過氧化苯甲醯
抗生素
水楊酸
其他

第 8 章：歐洲痤瘡藥物市場分析 - 按配方

外用藥物
口服藥物

第 9 章：歐洲痤瘡藥物市場分析 - 按類型

處方藥
非處方藥

第 10 章：歐洲痤瘡藥物市場分析 - 按痤瘡類型

非發炎性痤瘡
發炎性痤瘡

第 11 章：歐洲痤瘡藥物市場分析 - 按配銷通路

藥局和藥局
零售店
電子商務

第 12 章：歐洲痤瘡藥物市場 - 國家分析

歐洲
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 歐洲其他地區

第 13 章：痤瘡藥物市場-產業格局

概述
痤瘡藥物市場的成長策略
有機成長策略
- 概述
無機成長策略
- 概述
Farmapiel 提供的產品與其他公司痤瘡產品的比較

第 14 章：公司簡介

Teva Pharmaceutical Industries Ltd
Almirall SA
Johnson & Johnson
Sun Pharmaceutical Industries Ltd
Bausch Health Companies Inc
Galderma SA
Pfizer Inc
GSK Plc
Viatris Inc
Pierre Fabre SA

第 15 章：附錄

簡介目錄圖表

Product Code: BMIRE00030657

The Europe acne medication market was valued at US$ 1,963.08 million in 2022 and is expected to reach US$ 3,112.69 million by 2030; it is estimated to register at a CAGR of 6.0% from 2023 to 2030.

Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies Drive Europe Acne Medication Market

Adopting advanced technologies and data-driven approaches in the Europe acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to gain a better understanding of patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.

In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the Europe acne medication market.

Europe Acne Medication Market Overview

Europe ranks second in the global acne medication market. It is further anticipated to register a significant CAGR during the forecast period. The acne medication market growth in the region is ascribed to the increasing prevalence of acne and the growing presence of major players. The research-based pharmaceutical industry can play a key role in supporting the acne medication market growth in Europe and ensuring its future competitiveness in the global economy. Formel Skin, a Berlin-based business that is a pioneer in dermatology telehealth, announced the completion of a US$ 32.35 (30) million series fundraising round in January 2022. The funding was led by Singular and Heal Capital and supported by Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this funding, the company plans to undertake the long-term development and expansion of its remote skincare platform.

Europe Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Europe Acne Medication Market Segmentation

The Europe acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA are some of the leading companies operating in the Europe acne medication market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Acne Medication Market Landscape

4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment

5. Europe Acne Medication Market - Key Market Dynamics

5.1 Europe Acne Medication Market - Key Market Dynamics
5.2 Key Market Drivers
- 5.2.1 Increasing Prevalence of Severe Acne
- 5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
- 5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
- 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
- 5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Europe Market Analysis

7. Europe Acne Medication Market Analysis - by Therapeutic Class

7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acne Medication Market Analysis - by Formulation

8.1 Topical Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
- 8.2.1 Overview
- 8.2.2 Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acne Medication Market Analysis - by Type

9.1 Prescription Medicine
- 9.1.1 Overview
- 9.1.2 Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
- 9.2.1 Overview
- 9.2.2 Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acne Medication Market Analysis - by Acne Type

10.1 Non-Inflammatory Acne
- 10.1.1 Overview
- 10.1.2 Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
- 10.2.1 Overview
- 10.2.2 Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Acne Medication Market Analysis - by Distribution Channel

11.1 Pharmacies and Drug Stores
- 11.1.1 Overview
- 11.1.2 Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
- 11.2.1 Overview
- 11.2.2 Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
- 11.3.1 Overview
- 11.3.2 E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Europe Acne Medication Market - Country Analysis

12.1 Europe
- 12.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.2 Germany
  - 12.1.1.3 Germany: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.3.2 Germany: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.3.3 Germany: Acne Medication Market Breakdown, by Type
    - 12.1.1.3.4 Germany: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.4 France
  - 12.1.1.5 France: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.5.2 France: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.5.3 France: Acne Medication Market Breakdown, by Type
    - 12.1.1.5.4 France: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.5.5 France: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.6 UK
  - 12.1.1.7 UK: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.7.2 UK: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.7.3 UK: Acne Medication Market Breakdown, by Type
    - 12.1.1.7.4 UK: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.8 Italy
  - 12.1.1.9 Italy: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.9.2 Italy: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.9.3 Italy: Acne Medication Market Breakdown, by Type
    - 12.1.1.9.4 Italy: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.10 Spain
  - 12.1.1.11 Spain: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.11.2 Spain: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.11.3 Spain: Acne Medication Market Breakdown, by Type
    - 12.1.1.11.4 Spain: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.12 Rest of Europe
  - 12.1.1.13 Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type
    - 12.1.1.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

14.1 Teva Pharmaceutical Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Almirall SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson & Johnson
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bausch Health Companies Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Galderma SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Pfizer Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 GSK Plc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Viatris Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Pierre Fabre SA
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Acne Medication Market Segmentation
Table 2. Topical Medication
Table 3. Oral Medication
Table 4. Patient Population undergoing Acne Treatment from 2020-2023
Table 5. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
Table 6. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
Table 7. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 8. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
Table 9. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 10. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 11. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 12. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 13. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 14. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 15. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 16. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 17. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 18. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 19. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 20. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 21. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 22. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 23. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 24. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 25. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 26. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 27. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 28. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 30. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 31. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 32. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 33. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 34. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 35. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 36. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 37. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 38. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 39. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 40. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 41. Recent Organic Growth Strategies in Acne Medication Market
Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market
Table 43. Glossary of Terms, Acne Medication Market

List Of Figures

Figure 1. Europe Acne Medication Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acne Medication Market Revenue (US$ Million), 2022-2030
Figure 5. Europe Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
Figure 6. Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Acne Medication Market Share (%) - by Formulation (2022 and 2030)
Figure 12. Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Europe Acne Medication Market Share (%) - by Type (2022 and 2030)
Figure 15. Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
Figure 18. Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 21. Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 25. Europe: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 26. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Growth Strategies in Acne Medication Market